BiotechTube
Home/Montis Biosciences/Federico Grossi
FG

Federico Grossi

Clinical Advisor & Acting CMO

Montis Biosciences

Therapeutic Areas

Neuroinflammatory DiseasesAutoimmune DiseasesNeurodegenerative DiseasesOphthalmic DiseasesOncology

Montis Biosciences Pipeline

DrugIndicationPhase
Anti-C1q AntibodyGuillain-Barré Syndrome (GBS) & other neuroinflammatory diseasesPreclinical
Anti-CD93 AntibodyLung Squamous Cell Carcinoma (LUSC)Preclinical

Leadership Team at Montis Biosciences

GB
Gil Beyen
CEO
MB
Mo Benkheil
VP Research & Development
LD
Luc Dochez
Chairman of the Board
View full Montis Biosciences profile